Viewing Study NCT03602820


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT03602820
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-18
First Post: 2018-07-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)
Sponsor: Spark Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module